ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Lenalidomid-Teva 7.5 mg, Hartkapseln - 21
67460003 Teva Pharma AG
Lenalidomid-Teva 7.5 mg, Hartkapseln05.11.2019
Generic05.11.2019
Lenalidomide (L04AX04) 
WHO-DDD 
07.16.10.21
07.16.40. 
A  
Yes 
IP 
726.28Yes
    
10 %851.00
7680674600039Synthetika
  
Composition
lenalidomidum 7.5 mg ut lenalidomidi hydrochloridum monohydricum, silica colloidalis anhydrica, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.018 mg, talcum, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Lenalidomidum7.5 mg
BAG: Active AgentDose
Lenalidomidum7.5 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
Ammoniae Solutio30  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Per Centum  
Pro Capsula  
Propylenglycol  
Silica Colloidalis Anhydrica  
Talcum  
 
Source
Data was imported : 04.04.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home